Related Experiment Videos
Multidisciplinary treatment for resectable pancreatic cancer
Summary
A new multidisciplinary treatment protocol significantly improved the one-year survival rate for pancreatic carcinoma patients. This approach combines surgery, irradiation, and chemotherapy, offering better outcomes than surgery alone.
Area of Science:
- Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Pancreatic carcinoma has a poor prognosis with conventional treatments.
- Radical surgical procedures alone are often insufficient for a cure.
Purpose of the Study:
- To evaluate a multidisciplinary treatment protocol for pancreatic carcinoma.
- To assess the efficacy of combined-modality therapy in improving patient survival.
Main Methods:
- An extended pancreatic resection was performed.
- Intra-operative irradiation (3,000 rad electrons) and mitomycin C infusion were administered.
- Post-operative chemotherapy with mitomycin C was given intravenously or via Seldinger's method.
Main Results:
- The one-year survival rate was 86% in the eight treated patients.
- This survival rate is significantly higher than the 28% observed with conventional radical pancreatectomy (1962-1983).
- The post-operative course was uneventful for all patients.
Conclusions:
- Pancreatic carcinoma is unlikely to be cured by surgical procedures alone.
- A multidisciplinary treatment protocol is essential for improving the prognosis of pancreatic cancer.
- Combined-modality therapy shows promise for better outcomes in pancreatic cancer patients.